Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001104659-26-016662·ADAR1 Capital Management, LLC
Schedule 13G ownership disclosure
Ovid therapeutics, Inc.
Common Stock, par value $0.001 per share · CUSIP: 690469101
Event date: 2025-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- ADAR1 Capital Management, LLC
Shares: 9,284,166.00 · Class: 6.9%
- ADAR1 Capital Management GP, LLC
Shares: 9,284,166.00 · Class: 6.9%
- Daniel Schneeberger
Shares: 9,284,166.00 · Class: 6.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-26-016662
- Form type
- SCHEDULE 13G
- Filer
- ADAR1 Capital Management, LLC
- CIK
- CIK 1940272
- Filed
- Feb 17, 2026
- Reporting period
- Dec 31, 2025
- Description
- Schedule 13G beneficial ownership